PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180702
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180702
Nucleic Acid Testing Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Factors such as extensive adoption of genetic engineering by research institutes and pharmaceutical companies, technological advancement in diagnostic technique, sensory technology enables the rapid analysis, rising awareness about molecular diagnostic testing driving the market growth of nucleic acid testing globally.
The report titled "Nucleic Acid Testing Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall nucleic acid testing market along with the market size and estimates for the duration of 2020 to 2030. The research study covers in-depth analysis of market segments based on technology, application and different geographical regions.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global nucleic acid testing market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global nucleic acid testing market. This report concludes with company profiles section that highlights major information about the key players engaged in global nucleic acid testing market. In-depth competitive environment analysis and historical years (2021) market size data are also provided in the report.
Nucleic acid testing or nucleic acid amplification testing is generally abbreviated as NAT or NAAT. Variations exist in genome sequences of every individual; that makes NAT an ideal technique for identification of different disorders such as cancer, infectious diseases, genetic disorders, and mitochondrial disorders. Factors such as rapid, sensitive and specific methods compared to the traditional methods of diagnosis is driving the market growth of nucleic acid testing. NAT is widely used to detect and identify organisms for diagnosis, prognosis, and treatment of diseases. Previously NAT was used to screen HIV and HCV virus, however, its application has extended to detect human T-lymph tropic virus, treponema pallidum, hepatitis B virus, west nile virus, plasmodium and trypanosoma. It is observed that, in the base year 2016 infectious diseases held largest market share. NAT is capable of identifying genotypes and subtypes, determining resistance to particular antibiotics, and identifying viral load. All these factors are influencing the market growth of infectious disease segment. Some unique factors such as identification of fastidious bacteria, bacterial resistance testing, determination of bacterial infection after antibiotics are increasing the demand for NAT in identification of infectious disease. In recent years, NAT extensively used for early diagnosis of genetic variations and prevention of cancer. It is estimated that, NAT will play an important role in personalized and predictive medicine in future to avoid adverse reaction of medicines.
Nucleic acid test (NAT) is also known as nucleic acid amplification test (NAAT), is molecular technique used as screening method to detect genetic material such as DNA or RNA. NAT can detect pathogens, it is capable of detecting infectious donations faster than current tests because it detects genetic material rather than antigens or antibodies. Due to its accuracy and specificity demand for nucleic acid testing has increased in recent years. Sample extraction, amplification and target amplicon detection are the major process involved in NAT. Nucleic acid amplification perform by using three methods such as target amplification systems, probe amplification systems and signal amplification. It is observed that target amplification methods such as polymerase chain reaction, strand displacement amplification, ligase chain reaction and transcription-mediated amplification are most widely used in market. In the base year 2021, polymerase chain reaction was observed as the largest revenue generating segment as it is lower cost technique play fundamental role in disease detection, cloning, DNA typing, structural analysis, sequencing, mutation analysis and mapping.
Nucleic acid testing is technique that involves amplification and detection of genetic material such as DNA or RNA. Variations exist in genome sequences of every individual, it makes NAT an ideal technique for detection of different disorder, prenatal screening and carrier screening. Technological advances in diagnostic method, increase in prevalence of infectious and genetic disease are driving the growth of NAT market. It is observed that NAT is widely accepted diagnostic technique in developed countries. Currently, NAT has been adopted in several countries such as Canada, France, Australia, New Zealand, South Africa, and other countries in Europe and Asia. In base year 2021, North America was largest contributor in global nucleic acid testing market and occupied a significant portion of the global market. United States observed as largest revenue generating market in North America. Factors such as technological advancement, extensive adoption of genetic engineering and higher investment in R&D activities driving the market growth of NAT in North America. Asia Pacific is anticipated to show fastest growth rate during forecast period. Factors such as improving economic condition, populous countries and increasing demand of NAT would drive the market growth in Asia Pacific region during forecast period.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Nucleic Acid Testing market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Nucleic Acid Testing market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Technology
Polymerase chain reaction (PCR)
Strand Displacement Amplification (SDA)
Trocar Ligase chain reaction (LCR)
Transcription-mediated amplification (TMA)
Other
Applications
Infectious Disease
Genetic Disorders
Cancer
Forensic Testing
Other
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Nucleic Acid Testing market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Nucleic Acid Testing market?
Which is the largest regional market for Nucleic Acid Testing market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Nucleic Acid Testing market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Nucleic Acid Testing market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Nucleic Acid Testing Market
- 2.2. Global Nucleic Acid Testing Market, By Technology, 2021 (US$ Million)
- 2.3. Global Nucleic Acid Testing Market, By Applications, 2021 (US$ Million)
- 2.4. Global Nucleic Acid Testing Market, By Geography, 2021 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2021
3. Nucleic Acid Testing Market: Competitive Analysis
- 3.1. Market Positioning of Key Nucleic Acid Testing Market Vendors
- 3.2. Strategies Adopted by Nucleic Acid Testing Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Nucleic Acid Testing Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Nucleic Acid Testing Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Polymerase chain reaction (PCR)
- 5.3.2. Strand Displacement Amplification (SDA)
- 5.3.3. Trocar Ligase chain reaction (LCR)
- 5.3.4. Transcription-mediated amplification (TMA)
- 5.3.5. Other
6. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Infectious Disease
- 6.3.2. Genetic Disorders
- 6.3.3. Cancer
- 6.3.4. Forensic Testing
- 6.3.5. Other
7. North America Nucleic Acid Testing Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 7.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 7.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 7.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 7.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 7.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Nucleic Acid Testing Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.4.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.5.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 8.4.1.6.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Nucleic Acid Testing Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.4.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.5.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 9.4.1.6.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Nucleic Acid Testing Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 10.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 10.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 10.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 10.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 10.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Nucleic Acid Testing Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 11.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 11.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 11.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 11.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
- 11.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Automatic Liquid Packaging Solutions, Llc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Catalent, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. HealthStar, Inc.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Hunan Chinasun Pharmaceutical Machinery Co., Ltd.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Mahanagar Engineering Pvt. Ltd.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. Pharmapack Co., Ltd.
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Rommelag Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. Shanghai Pharmaceutical Machinery Co., Ltd.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. Shanghai Sunway International Trade Co., Ltd.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. Truking Technology Ltd.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
- 12.11. Unither
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Portfolio
- 12.11.4. Strategic Initiatives
- 12.12. Weiler Engineering, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Portfolio
- 12.12.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 2 Global Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 3 North America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 4 North America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 5 U.S. Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 6 U.S. Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 7 Canada Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 8 Canada Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 9 Rest of North America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 10 Rest of North America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 11 UK and European Union Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 12 UK and European Union Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 13 UK Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 14 UK Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 15 Germany Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 16 Germany Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 17 Spain Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 18 Spain Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 19 Italy Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 20 Italy Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 21 France Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 22 France Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 23 Rest of Europe Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 24 Rest of Europe Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 25 Asia Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 26 Asia Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 27 China Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 28 China Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 29 Japan Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 30 Japan Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 31 India Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 32 India Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 33 Australia Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 34 Australia Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 35 South Korea Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 36 South Korea Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 37 Latin America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 38 Latin America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 39 Brazil Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 40 Brazil Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 41 Mexico Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 42 Mexico Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 43 Rest of Latin America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 44 Rest of Latin America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 45 Middle East and Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 46 Middle East and Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 47 GCC Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 48 GCC Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 49 Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 50 Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
- TABLE 51 Rest of Middle East and Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
- TABLE 52 Rest of Middle East and Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Nucleic Acid Testing Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Nucleic Acid Testing Market: Quality Assurance
- FIG. 5 Global Nucleic Acid Testing Market, By Technology, 2021
- FIG. 6 Global Nucleic Acid Testing Market, By Applications, 2021
- FIG. 7 Global Nucleic Acid Testing Market, By Geography, 2021
- FIG. 8 Market Geographical Opportunity Matrix - Global Nucleic Acid Testing Market, 2021
- FIG. 9 Market Positioning of Key Nucleic Acid Testing Market Players, 2021
- FIG. 10 Global Nucleic Acid Testing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 11 Global Nucleic Acid Testing Market, By Technology, 2021 Vs 2030, %
- FIG. 12 Global Nucleic Acid Testing Market, By Applications, 2021 Vs 2030, %
- FIG. 13 U.S. Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 14 Canada Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 15 Rest of North America Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 16 UK Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 17 Germany Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 18 Spain Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 19 Italy Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 20 France Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 21 Rest of Europe Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 22 China Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 23 Japan Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 24 India Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 25 Australia Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 26 South Korea Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 27 Rest of Asia Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 28 Brazil Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 29 Mexico Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 30 Rest of Latin America Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 31 GCC Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 32 Africa Nucleic Acid Testing Market (US$ Million), 2020 - 2030
- FIG. 33 Rest of Middle East and Africa Nucleic Acid Testing Market (US$ Million), 2020 - 2030
